LncRNA NONHSAT227443.1 Confers Esophageal Squamous Cell Carcinoma Chemotherapy Resistance by Activating PI3K/AKT Signaling via Targeting MRTFB
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Abstract
Introduction: Esophageal cancer presents significant challenges due to limited treatment options and poor prognosis, particularly in advanced stages. Dysregulated long non-coding RNAs (lncRNAs) are implicated in cancer progression and treatment resistance. This study investigated the roles of dysregulated lncRNA NONHSAT227443.1, identified through lncRNA-seq, and its downstream target gene MRTFB in esophageal squamous cell carcinoma (ESCC). Methods: Dysregulated lncRNAs were identified through lncRNA-seq in esophageal cancer tissues with varying chemotherapy response. The regulatory interaction of overexpressed NONHSAT227443.1 was assessed using quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting. Functional assays, including cell viability, cell proliferation, and flow cytometry analyses, were performed to comprehensively investigate the influence of NONHSAT227443.1 and its downstream molecules on ESCC. Results: NONHSAT227443.1 was significantly overexpressed in paclitaxel plus platinum chemotherapy non-responders and esophageal cancer cell lines. Chemotherapy exposure led to diminished NONHSAT227443.1 expression. NONHSAT227443.1 negatively regulated MRTFB expression, and their combined dysregulation correlated with increased cancer activity, proliferation, and suppressed apoptosis. Diminished MRTFB expression was associated with PI3K/AKT pathway activation. Conclusion: Our study provides insights into NONHSAT227443.1 and MRTFB roles in esophageal cancer, contributing to aggressive traits and treatment resistance. NONHSAT227443.1 and MRTFB may serve as potential therapeutic targets to enhance the response to paclitaxel plus platinum chemotherapy in non-responsive cases.Keywords
This publication has 40 references indexed in Scilit:
- Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene‐induced senescenceEMBO Molecular Medicine, 2013
- Myocardin related transcription factors are required for coordinated cell cycle progressionCell Cycle, 2013
- Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinomaProceedings of the National Academy of Sciences, 2012
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Linking actin dynamics and gene transcription to drive cellular motile functionsNature Reviews Molecular Cell Biology, 2010
- Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486Proceedings of the National Academy of Sciences of the United States of America, 2010
- CCN1 protects cardiac myocytes from oxidative stress via β1 integrin–Akt pathwayBiochemical and Biophysical Research Communications, 2007
- Actin’ together: serum response factor, its cofactors and the link to signal transductionTrends in Cell Biology, 2006
- The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesisGenes & Development, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006